Clin2
NCT06558422Likely a fitNot yet recruiting

Insulin resistance study using a pancreatic clamp

Insulin ResistanceHyperinsulinemiaMetabolic Dysfunction Associated Steatotic Liver DiseaseNon-Alcoholic Fatty Liver DiseasePrediabetic StateObesity

Treatments studied

Part of Digestive system, Hormones & metabolism clinical trials.

This study tests how your body responds to insulin by using a special test called a pancreatic clamp. It may help researchers understand insulin resistance better and find new ways to treat it.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
36 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are 18 to 65 years old
  • Your body mass index (BMI) is between 27 and 50
  • You have prediabetes or insulin resistance (but not diabetes)
  • You are willing to follow study procedures, including staying in bed and not using your phone during a test

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07403604Recruiting· Phase 1
Lowering Insulin to Reduce Fat Buildup in the Liver

This study tests if lowering insulin levels can reduce fat buildup in the liver for people with a fatty liver condition called MASLD. It's looking for adults who are overweight and have early signs of insulin resistance but not diabetes.

New York, New York
NCT06592261Recruiting· Phase 1
Insulin suppression test for weight groups

This study tests a new way to measure how the body handles insulin in people with different body weights. It may help researchers understand insulin resistance better.

New York, New York
NCT02193295Recruiting
Testing how changing fats affects insulin resistance

This study tests how “lipid” (fat) changes in the body affect insulin resistance, which is when the body doesn’t respond to insulin as well as it should. Because it’s done in healthy people, it’s mainly looking at basic biology and may help guide future treatments.

New Haven, Connecticut
NCT06354088Recruiting· Phase 1
Study of alpelisib for insulin resistance

This study tests a single dose of a drug called alpelisib (a PI3K inhibitor) to see how it affects insulin and blood sugar in people who are either insulin sensitive or insulin resistant. The goal is to understand why some people become resistant to insulin, which may help find new treatments for diabetes and related conditions.

New York, New York
NCT05743868Recruiting
Study of how insulin resistance affects blood fats

This study looks at how differences in insulin resistance may change how the liver makes triglycerides (a type of blood fat). It may help researchers understand why some people have higher triglycerides and how to target them better.

Amsterdam
NCT07516509Recruiting
How muscle cells respond to blood sugar in different body types

This research study examines how muscle cells handle blood sugar differently depending on whether someone is lean or has obesity, and whether their body resists insulin. Researchers will take small muscle samples to understand the genetic differences, which may help develop better treatments for insulin resistance and metabolic health.

Orlando, Florida

Hear when a new Insulin Resistance trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.